Cargando…
Design, Synthesis and Evaluation of New Indolylpyrimidylpiperazines for Gastrointestinal Cancer Therapy
Human A(3) adenosine receptor hA(3)AR has been implicated in gastrointestinal cancer, where its cellular expression has been found increased, thus suggesting its potential as a molecular target for novel anticancer compounds. Observation made in our previous work indicated the importance of the carb...
Autores principales: | Tan, Aaron, Babak, Maria V., Venkatesan, Gopalakrishnan, Lim, Clarissa, Klotz, Karl-Norbert, Herr, Deron Raymond, Cheong, Siew Lee, Federico, Stephanie, Spalluto, Giampiero, Ong, Wei-Yi, Chen, Yu Zong, Loo, Jason Siau Ee, Pastorin, Giorgia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832257/ https://www.ncbi.nlm.nih.gov/pubmed/31614517 http://dx.doi.org/10.3390/molecules24203661 |
Ejemplares similares
-
Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A(2A) and dopamine D(2) receptors for Parkinson's disease treatment
por: Shao, Yi-Ming, et al.
Publicado: (2018) -
Pyrazolo Derivatives as Potent Adenosine Receptor Antagonists: An Overview on the Structure-Activity Relationships
por: Cheong, Siew Lee, et al.
Publicado: (2011) -
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes
por: Bolcato, Chiara, et al.
Publicado: (2007) -
Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors
por: Salmaso, Veronica, et al.
Publicado: (2023) -
The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives
por: Federico, Stephanie, et al.
Publicado: (2015)